Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Michael Diiorio, Kevin Kennedy, Jean W. Liew, Michael S. Putman, Emily Sirotich, Sebastian E. Sattui, Gary Foster, Carly Harrison, Maggie J. Larché, Mitchell Levine, Tarin T. Moni, Lehana Thabane, Suleman Bhana, Wendy Costello, Rebecca Grainger, Pedro M. MacHado, Philip C. Robinson, Paul Sufka, Zachary S. Wallace, Jinoos YazdanyMonique Gore-Massy, Richard A. Howard, More A. Kodhek, Nadine Lalonde, Laura Ann Tomasella, John Wallace, Akpabio Akpabio, Deshiré Alpízar-Rodríguez, Richard P. Beesley, Francis Berenbaum, Inita Bulina, Eugenia Yupei Chock, Richard Conway, Alí Duarte-García, Eimear Duff, Tamer A. Gheita, Elizabeth R. Graef, Evelyn Hsieh, Lina El Kibbi, David F.L. Liew, Chieh Lo, Michal Nudel, Aman Dev Singh, Jasvinder A. Singh, Namrata Singh, Manuel F. Ugarte-Gil, Jonathan S. Hausmann, Julia F. Simard, Jeffrey A. Sparks
Dive into the research topics of 'Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey'. Together they form a unique fingerprint.